Backlink: VISIONTIMES

The Biden Administration’s Department of Health and Human Services has spent $290 million securing supplies of a “drug for use in radiological and nuclear emergencies,” according to an Oct. 4 Press Release.

The drug is called Nplate and manufactured by Amgen USA Inc., which the HHS says “is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS).”